Without clear timelines and accountability, Ireland risks falling short of its goal to end new HIV transmissions by 2030.
Indian generic manufacturers will produce lenacapavir, a near 100% effective, six-month injectable HIV prevention drug, ...
A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year.
Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...
A game-changer in HIV prevention. moses sagwe26 September 2025 - 14:54 ...
The twice-yearly drug has been hailed as a medical breakthrough that could change the course of the HIV epidemic. View on ...
The United Nations agency focusing on the HIV/AIDS pandemic could close by the end of next year as the U.N. restructures in ...
Khaleej Times on MSN
HIV-prevention drug to be available for $40 a year from 2027
The two organisations have entered into separate agreements with Indian pharmaceutical companies to produce cheaper generic ...
TB/HIV patients with advanced HIV disease can be successfully managed in integrated TB/HIV MoH clinics in rural Kenya. Treatment outcomes improve with time, likely reflecting a variety of factors ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback